Laboratoires Pierre Fabre

[Inno 360°] Did you know that the hormonal cycle is the #1 aggravating factor for female acne? 🧬 Acne is the most common skin condition in the world, and 60% of patients are women. This phenomenon becomes particularly pronounced before and during menstruation, when hormone levels drop. 🔬With over 25 years of expertise in acne science and more than a decade of dedicated research, Ducray has developed Keracnyl, the first anti-blemish serum with high-efficacy action throughout the menstrual cycle. Thanks to the patented synergy of Laboratoires Pierre Fabre’s anti-inflammatory actives - Myrtacine® and Celastrol - blemishes are targeted at the source, reducing pimples by 58% before and during menstruation. And that’s not all: enriched with benchmark dermatological actives, Keracnyl hydrates and soothes the skin, delivering 3x fewer visible marks and a 79% reduction in sebum secretion. ✨ A breakthrough in acne care. #NewWaysToCare #PierreFabre #Ducray #Keracnyl #Acne #Dermatology

[Inside the Labs] Back with our General Managers around the world. 🌍   Do you ever wonder what it’s like to work at Laboratoires Pierre Fabre?   We asked Antonin Godin, Lisa Morris, Philippe De Carvalho and adriana herrera to sum up their answers in a few words. And they came with the following ones : PURPOSE, PASSION and CONSTANTLY RENEWED ENERGY !!     Discover more by watching the video.   #NewWaysToCare #PierreFabre #Leadership

[Numbers that Matter] Relentlessly innovating for patients 💙 At Laboratoires Pierre Fabre, we’re strengthening our medical leadership by accelerating R&D investments in precision oncology, rare diseases and dermo-cosmetics. 🩺 Oncology accounted for 58% of our R&D investments in 2024. 🧪 Our dermo-cosmetics R&D bridges medical science and skin and haircare, with the aim of developing innovative solutions for all skin types and pathologies. 🤝 And we don’t walk alone: we collaborate with 1,300 medical experts worldwide, thus enriching medical knowledge and paving the way for better treatments. Read more about the new energy that feeds our innovation in the 2025 Annual Report 👉 https://lnkd.in/e4XNsK5H #NewWaysToCare #PierreFabre #MedicalCare #Oncology #RD #Innovation

We are pleased to announce a major milestone for Laboratoires Pierre Fabre in China 🙌 Our commitment to advancing patient care and delivering precision medicine has taken a significant step forward with the recent approval of our therapeutic solution for the treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer, after prior systemic therapy.   By integrating cutting-edge science with patient-centered care, we aim to significantly enhance the quality of life for patients and contribute to the global fight against cancer 💙. This achievement underscores our strategic focus on China and our ongoing collaboration with healthcare professionals and authorities to make innovative treatments accessible.   🚀 We continue to lead the way in oncology, with a robust portfolio that spans multiple therapeutic fields to address significant unmet medical needs. #PierreFabre #NewWaysToCare #Oncology #Innovation

[Inside the Labs] Accelerating through sustainable operations 🚀 At Laboratoires Pierre Fabre, nearly 90% of our products are proudly manufactured in France. Our Operations teams are committed to minimize our environmental footprint, as shown by three key investments underway : 👉 A “dry factory” project at our dermo-cosmetic manufacturing site near Castres … to save on water. 👉 A new treatment process of volatile organic compounds at our fine chemistry site in Gaillac … to save on water, energy and carbon emissions. 👉 Expansion of the Avène plant with the replacement of several utility systems … to save on energy consumption.   “We want to cultivate our approach of “operating sustainably providing responsible, agile, competitive solutions to support the company’s international expansion.” - Vincent Huraux Chief Operating Officer. 📘 Discover our full vision in our 2025 Annual Report: https://lnkd.in/e4XNsK5H  #NewWaysToCare #PierreFabre #PurposeDriven #Commitments #Environment

[Inside the Labs] Our interview series continues with our General Managers around the world. 🌍 💬💪 This time, we’re diving into the visions of Antonin Godin, Lisa Morris, Philippe De Carvalho, Nicolas Zombré and adriana herrera for Laboratoires Pierre Fabre, getting great insights from sharp questions. How do they describe Laboratoires Pierre Fabre, and what would its superpower be? Their answers are both meaningful and playful. Next, we’ll talk dermocosmetics and skin myths. So keep an eye on our feed 😉 Your turn, can you answer these questions yourself? #NewWaysToCare #PierreFabre #Leadership #Management #CareCulture #BehindTheScenes

[Facts that Matter] At Pierre Fabre, listening to patients is at the core of our mission to advancing healthcare. 👥 This is why we have been conducting an international dermatology study since 2023, in collaboration with professors of dermatology and 12 patient associations. Known as ALL, this study is taking place in 20 countries with the participation of 50,000 patients. It has already generated 3 million data on the impact of multiple skin pathologies (acne, psoriasis, eczema …). By combining this wealth of information with open-source indicators and lifestyle factors, we have developed a predictive model for estimating the incidence of skin diseases by 2030 and adjust our research programs accordingly. This example reflects a non-negotiable conviction: patients must be at the heart of our innovation process. 📘 Find out more about our holistic approach to patients in our 2025 Annual Report 👉 https://lnkd.in/e4XNsK5H #NewWaysToCare #PierreFabre #Healthcare #Dermatology #Datadriven #Innovation

[Inside the Labs] Part three: short questions and sharp insights, with our General Managers around the world. 🌍 On this third episode, Antonin Godin, Lisa Morris, Philippe De Carvalho, Nicolas Zombré and adriana herrera share brief but revealing perspectives on their daily rhythm and leadership style. 💻 Their preferred digital tool. ☕️ The role of a coffee break in their day. ☀️ Their optimal time for productivity. Now that we’ve met our world managers and learned how they think and lead, we’ll get deeper, on the next episode, into their vision of Laboratoires Pierre Fabre and their activities ! #NewWaysToCare #PierreFabre #Leadership #Management #CareCulture #BehindTheScenes

[Partners in Care] To accelerate the development of targeted therapies in oncology, we constantly draw our energy from trusted partnerships. In our 2025 Annual Report, Francesco Hofmann, Head of Pierre Fabre Medical Care R&D, shares meaningful insights about our partnership-based approach to innovation, through a forward-looking discussion: 🎯 The benefits of a partnership-based strategy. 🧠 The complementarity of external expertises.   🤝 The different kinds of partners we work with. “With this approach, we are confident that we will be able to offer new therapeutic options to patients more quickly.” - Francesco Hofmann 📘 Access their full interview and explore additional insights in our 2025 Annual Report: 👉 https://lnkd.in/e4XNsK5H #NewWaysToCare #PierreFabre #MEdicalCare #Innovation #Oncology #RD #AnnualReport 

At Laboratoires Pierre Fabre, we are proud to strengthen our long-standing commitment to skin health and oncology by supporting the 15th European Post-Chicago Melanoma/Skin Cancer Meeting as a Gold Sponsor. This key congress, organized under the auspices of the European Association of Dermato-Oncology (EADO) and the Melanoma World Society - MWS, brings together leading experts to discuss the most recent data in the field . 🤝 We are pleased to contribute to this collective effort by facilitating scientific exchange, supporting medical education, and providing spaces for meaningful dialogue at our booth. 🎥 We are also proud to sponsor the 13th European School of Dermato-Oncology (ESDO) to promote broader access to the latest advances. Our teams look forward to meeting healthcare professionals, researchers, and partners in Hamburg to collaborate and continue driving progress for patients. #PierreFabre #NewWaysToCare #Healthcare